Answer:
This pharmaceutical agent could be described as an RNA molecule capable of increasing the rate of chemical reactions (i.e., capable of catalysis), and effectively inhibiting the replication of HIV infection through an engineered process; generally, the pharmaceutical agent would serve as a good fit for anti-HIV application.